Fimepinostat in Treating Brain Tumors in Children and Young Adults
Status:
Recruiting
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
This trial studies how well fimepinostat works in treating patients with newly diagnosed
diffuse intrinsic pontine glioma, or medulloblastoma, or high-grade glioma that have come
back. Fimepinostat may stop the growth of tumor cells by blocking some of the enzymes needed
for cell growth.
Phase:
Early Phase 1
Details
Lead Sponsor:
Sabine Mueller, MD, PhD
Collaborators:
Cannonball Kids' Cancer Foundation Curis, Inc. Pacific Pediatric Neuro-Oncology Consortium